Publications by authors named "Lotfali Jamshidi"
Iran J Kidney Dis
March 2011
Article Synopsis
- Hyperhomocysteinemia is prevalent in patients with end-stage renal disease and is linked to cardiovascular risk, prompting a study on folic acid's impact on serum homocysteine levels in hemodialysis patients.
- Patients were divided into four groups receiving varying doses of folic acid (2, 5, 10, and 15 mg/d) over four weeks, and their serum homocysteine levels were monitored.
- The results indicated that while folic acid significantly reduced homocysteine levels, there was no notable difference in effectiveness across the different doses, suggesting that a daily dose of 2 mg is sufficient.
